GLP-1 drugs for addiction: Confidence grows in new treatment option
WERNERSVILLE, Pa. — To make sense of the reds and greens dancing across a computer monitor displaying a…
Alaska to receive $1.8 million in latest national opioid settlement
Alaska Attorney General Treg Taylor announced Friday that the State of Alaska will receive approximately $1.8 million as…
FDA to consider drug affordability when speeding up approvals: Makary
The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals…
FDA focuses attention on rejected drug decisions
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Two-faced gene variant appears good for men, bad for women
In men, this gene variant, known as rs6190, appears to help build muscle mass and reduce diabetes risk, according…
Americans must stop subsidizing the price of drugs in other countries
President Trump is right that Americans often pay too much for prescription drugs, and that other countries aren’t…
Novo Nordisk ends Wegovy deal with Hims & Hers
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has…
New lab method accelerates diagnosis of genetic disorders of the immune system
A new laboratory method developed by researchers at Columbia University Vagelos College of Physicians and Surgeons may now…
Scientists Just Had a Breakthrough In Understanding Tylenol
If you’ve ever sought an over-the-counter solution for pain relief, odds are pretty good that you’ve reached for…
Eli Lilly’s Genetic Medicine Bet On Verve Therapeutics
Cambridge, MA – July 11: Verve CEO and cofounder Sekar Kathiresan. Cambridge company Verve … More Therapeutics announced…